DrugPatentWatch Database Preview
Drugs in MeSH Category Alkylating Agents
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma | JELMYTO | mitomycin | POWDER;PYELOCALYCEAL | 211728-001 | Apr 15, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Rk Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 203386-001 | Oct 13, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Urogen Pharma | JELMYTO | mitomycin | POWDER;PYELOCALYCEAL | 211728-001 | Apr 15, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Shilpa Medicare Ltd | BUSULFAN | busulfan | INJECTABLE;INJECTION | 210931-001 | Apr 18, 2019 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |